Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$1.7M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$279M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| FMR LLC | Jan 8, 2025 | Sell | 164,912 | $6.71 | $1.1M |
| FMR LLC | Jan 8, 2025 | Sell | 100,000 | $6.11 | $610,000 |
| FMR LLC | Jan 8, 2025 | Sell | 25,000 | $6.5 | $160,000 |
| FMR LLC | Jan 8, 2025 | Sell | 1,000 | $7.26 | $7,300 |
| Mulligan Richard | Sep 25, 2024 | Sell | 150,000 | $3.8878 | $580,000 |
| Yang Patrick Y | Mar 8, 2024 | Sell | 25,000 | $9.452 | $240,000 |
| AFEYAN NOUBAR | Feb 12, 2024 | Buy | 2,727,272 | $5.4999 | $15M |
| NELSEN ROBERT | Feb 8, 2024 | Buy | 727,272 | $5.5 | $4M |
| NELSEN ROBERT | Feb 8, 2024 | Buy | 363,637 | $5.5 | $2M |
| CRANDELL KEITH | Feb 8, 2024 | Buy | 727,272 | $5.5 | $4M |
| CRANDELL KEITH | Feb 8, 2024 | Buy | 363,637 | $5.5 | $2M |
| ARCH Venture Fund IX, L.P. | Feb 8, 2024 | Buy | 727,272 | $5.5 | $4M |
| ARCH Venture Fund IX, L.P. | Feb 8, 2024 | Buy | 363,637 | $5.5 | $2M |
| Hordo Christian | Dec 15, 2023 | Sell | 75,000 | $4.0013 | $300,000 |
| AFEYAN NOUBAR | Jun 7, 2023 | Sell | 177,240 | $6.2397 | $1.1M |
| AFEYAN NOUBAR | Jun 7, 2023 | Sell | 22,760 | $6.2397 | $140,000 |
| AFEYAN NOUBAR | Jun 6, 2023 | Sell | 181,461 | $6.3061 | $1.1M |
| AFEYAN NOUBAR | Jun 6, 2023 | Sell | 22,297 | $6.3061 | $140,000 |
| AFEYAN NOUBAR | May 26, 2023 | Sell | 72,670 | $6.2265 | $450,000 |
| AFEYAN NOUBAR | May 26, 2023 | Sell | 9,330 | $6.2265 | $58,000 |
| AFEYAN NOUBAR | May 25, 2023 | Sell | 102,245 | $6.3522 | $650,000 |
| AFEYAN NOUBAR | May 25, 2023 | Sell | 13,127 | $6.3522 | $83,000 |
| AFEYAN NOUBAR | May 24, 2023 | Sell | 308,290 | $6.5652 | $2M |
| AFEYAN NOUBAR | May 24, 2023 | Sell | 39,580 | $6.5652 | $260,000 |
What's the latest insider transaction for Sana Biotechnology?
The most recent insider transaction for Sana Biotechnology was conducted by FMR LLC, who sold 164,912 shares on January 8, 2025 at a price of $6.71 per share.
Which insider bought the most SANA stock over the last two years?
AFEYAN NOUBAR has bought the most SANA stock in the last 2 years, with a total value of $15M.
Which insider has sold the most SANA stock over the last two years?
AFEYAN NOUBAR has sold the most SANA stock in the last 2 years, with a total value of $6.1M.
What is the total value of insider transactions for Sana Biotechnology (SANA) in the last 2 years?
According to our estimates, the total value of insider transactions for Sana Biotechnology in the last 2 years is positive, amounting to $24M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Sana Biotechnology's market confidence?
Over the last 2 years, insider transactions for Sana Biotechnology have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
